YouTube

Pediatime Logo

YouTube: Subscribe to Pediatime!

Stay updated with the latest pediatric education videos.

Subscribe Now

Familial dysautonomia (Riley-Day syndrome) in Children

Definition and Epidemiology

Familial dysautonomia (FD) is a rare genetic disorder characterized by autonomic nervous system dysfunction and sensory neuropathy. It primarily affects individuals of Ashkenazi Jewish descent, with a carrier frequency of approximately 1:32 in this population. The condition is caused by mutations in the IKBKAP gene (ELP1), inherited in an autosomal recessive pattern.

Clinical Manifestations

Autonomic Dysfunction:

  • Cardiovascular instability
    • Orthostatic hypotension
    • Episodic hypertension
    • Tachycardia
  • Thermoregulatory dysfunction
    • Temperature instability
    • Hyperhidrosis
    • Absence of fever during infections
  • Gastrointestinal dysfunction
    • Dysphagia
    • Gastroesophageal reflux
    • Recurrent aspiration
    • Cyclic vomiting

Sensory Manifestations:

  • Decreased pain and temperature sensitivity
  • Absent corneal reflexes
  • Impaired taste
  • Absence of fungiform papillae on tongue
  • Decreased deep tendon reflexes

Other Features:

  • Developmental manifestations
    • Growth retardation
    • Delayed developmental milestones
    • Learning disabilities
  • Musculoskeletal features
    • Scoliosis
    • Kyphosis
    • Joint deformities
  • Ophthalmologic complications
    • Corneal ulceration
    • Optic nerve atrophy
    • Strabismus

Diagnosis

Genetic Testing:

Molecular genetic testing for IKBKAP gene mutations is the gold standard for diagnosis.

Clinical Diagnostic Criteria:

  • Major criteria:
    • Ashkenazi Jewish descent
    • Decreased deep tendon reflexes
    • Absence of overflow tears
    • Absent fungiform papillae
    • Decreased pain perception
  • Supporting features:
    • Recurrent aspiration
    • Skin blotching
    • Postural hypotension
    • Episodic hypertensive crises

Additional Diagnostic Studies:

  • Intradermal histamine test
  • Cardiovascular autonomic testing
  • Swallowing evaluation
  • Ophthalmologic examination
  • Orthopedic assessment

Management

Multidisciplinary Approach:

Management requires coordination among multiple specialists:

  • Neurologist
  • Gastroenterologist
  • Ophthalmologist
  • Orthopedic surgeon
  • Respiratory specialist
  • Physical therapist
  • Occupational therapist
  • Speech therapist
  • Genetic counselor

Specific Interventions:

1. Respiratory Management:

  • Chest physiotherapy
  • Postural drainage
  • Prevention and management of aspiration
  • Regular pulmonary function monitoring

2. Gastrointestinal Care:

  • Feeding modifications
    • Thickened liquids
    • Postural adjustments during feeding
    • Small, frequent meals
  • Gastrostomy tube placement when indicated
  • Anti-reflux measures
  • Nutritional supplementation

3. Cardiovascular Management:

  • Blood pressure monitoring
  • Hydration maintenance
  • Salt supplementation
  • Compression stockings
  • Medications for hypertensive crises

4. Ophthalmologic Care:

  • Regular eye examinations
  • Artificial tears
  • Protective eyewear
  • Monitoring for corneal complications

5. Orthopedic Management:

  • Regular spine monitoring
  • Bracing when indicated
  • Surgical intervention for severe scoliosis
  • Physical therapy program

Prognosis and Monitoring

Life Expectancy:

Variable, with many patients now surviving into adulthood with appropriate management. Major causes of mortality include:

  • Respiratory complications
  • Autonomic crises
  • Cardiovascular events

Regular Monitoring:

  • Growth and development tracking
  • Regular assessment of autonomic function
  • Monitoring for complications
  • Assessment of quality of life

Long-term Complications:

  • Progressive kyphoscoliosis
  • Chronic respiratory insufficiency
  • Renal involvement
  • Cognitive impairment

References and Further Reading

Note: References should be verified and updated regularly as medical knowledge evolves.

  1. Axelrod FB, Gold-von Simson G. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis. 2007;2:39.
  2. Norcliffe-Kaufmann L, Slaugenhaupt SA, Kaufmann H. Familial dysautonomia: History, genotype, phenotype and translational research. Prog Neurobiol. 2017;152:131-148.
  3. Palma JA, Norcliffe-Kaufmann L, Fuente-Mora C, et al. Current treatments in familial dysautonomia. Expert Opin Pharmacother. 2014;15(18):2653-2671.

Note: This document is intended for medical professionals and should be regularly updated based on new research and guidelines. Clinical judgment should always be exercised in the management of individual patients.



Powered by Blogger.